These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea]. Beyer J; Cordes U; Sell G; Schöffling K Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965 [No Abstract] [Full Text] [Related]
3. [Hypoglycemic activity and tolerance of glibenclamide-phenformin association]. Fanelli O; Bianchi G; Fascetti P; Trallori L Boll Chim Farm; 1971 Aug; 110(8):470-8. PubMed ID: 5002955 [No Abstract] [Full Text] [Related]
4. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models]. Lorch E; Gey KF; Sommer P Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964 [No Abstract] [Full Text] [Related]
5. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas]. Beyer J; Haupt E; Cordes U; Sell G; Schöffling K Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544 [No Abstract] [Full Text] [Related]
8. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Harrigan RA; Nathan MS; Beattie P Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816 [TBL] [Abstract][Full Text] [Related]
10. [Retrolective study design -- a new tool of evidence-based medicine]. Martin S Dtsch Med Wochenschr; 2005 Jul; 130 Suppl 2():S86-90. PubMed ID: 15988675 [No Abstract] [Full Text] [Related]
11. Hypoglycaemic drugs. Sarges R Prog Med Chem; 1981; 18():191-223. PubMed ID: 7045983 [No Abstract] [Full Text] [Related]
12. Biologically active 1,2-benzisothiazole derivatives. De A Prog Med Chem; 1981; 18():117-33. PubMed ID: 7045981 [No Abstract] [Full Text] [Related]